THE PRACTICAL CONSEQUENCES OF THE CHANGE OF THE HOME OFFICE’S POLICY ON CONTROLLED CANNABINOIDS CONTENT IN CBD PRODUCTS

A SURPRISING ABOUT-TURN IN HOME OFFICE POLICY IN RESPECT OF “EXEMPT PRODUCTS” UNDER THE MISUSE OF DRUGS REGULATIONS